DOJ Fraud and Health Care Enforcement: Latest Priorities, Trends, and Compliance Considerations
Health care organizations continue to operate in an increasingly complex enforcement environment. As Department of Justice (DOJ) priorities evolve, recent developments, including the creation of the National Fraud Enforcement Division and updates to the DOJ's corporate self-disclosure framework, are reshaping compliance expectations and enforcement risk across the industry.
Watch this on-demand webinar featuring attorneys from Mintz's Health Care Enforcement and White Collar Defense Practices as they discuss the latest enforcement priorities, emerging areas of scrutiny, and practical steps organizations can take to strengthen compliance programs and mitigate risk.
View the slide deck here.
In This Recording
Our panel explores:
- DOJ health care fraud and False Claims Act (FCA) enforcement priorities heading into the second half of 2026, including the implications of DOJ's fraud enforcement reorganization
- Key risk areas attracting regulatory attention, including Medicare Advantage, laboratory and diagnostic testing services, telehealth, wound care, and referral-source arrangements
- The expanding use of data analytics in enforcement activities and new whistleblower incentives driving qui tam filings
- Novel FCA theories and emerging enforcement trends
- Practical considerations for compliance, auditing, investigations, disclosures, and risk assessments
This program is designed for:
- In-house legal counsel
- Compliance and audit professionals
- Health system executives
- Portfolio company leadership teams
- Private equity sponsors and investors focused on the health care sector
Authors
Karen Lovitch
Member / Chair, Health Law Practice & Chair, Health Care Enforcement Defense Practice
Karen advises industry clients on regulatory, transactional, operational, and enforcement matters. She has deep experience handling FCA investigations and qui tam litigation for laboratories and diagnostics companies.
Eoin P. Beirne
Member / Co-chair, White Collar Defense and Government Investigations Practice
Eóin P. Beirne is Co-chair of Mintz’s White Collar Defense and Government Investigations Practice. He guides clients from a wide range of industries through federal and state investigations and enforcement proceedings.
Samantha P. Kingsbury
Of Counsel
Samantha P. Kingsbury is Of Counsel at Mintz. She advises clients on regulatory and enforcement matters and has deep experience handling violations of the federal anti-kickback statute and FCA investigations for clinical laboratories and hospitals.
Nick A. LaPalme
Associate
Nick A. LaPalme is an Associate at Mintz who focuses his practice on white collar defense, internal investigations, and complex commercial litigation matters. He works with clients across a variety of industries, including financial services.